Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.

Joel Christoffer Marrs

TitleAssoc Professor-Clinical
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-PEDS
Phone303/724-5780
ORCID ORCID Icon0000-0003-0392-3866 Additional info

    Collapse Biography 
    Collapse education and training
    Butler University, Indianapolis, INPharmD05/2004Pharmacy
    Mount Carmel Medical Center, Columbus, OHPGY106/2005Pharmacy Practice
    University of Colorado School of Pharmacy, Denver, COPGY206/2006Ambulatory Care/Family Medicine
    University of Colorado School of Public Health, Aurora, COMPH08/2019Epidemiology

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. White RT, Sirek ME, Marrs JC. Oral Oncolytics and Cardiovascular Risk Management and Monitoring. J Cardiovasc Pharmacol. 2023 Oct 01; 82(4):266-280. PMID: 37499057.
      View in: PubMed
    2. Marrs JC, Orlando ST, Saseen JJ, Novins-Montague S, Sandy LC, Waughtal J, Glorioso TJ, Ho PM. Description of patient questions received by clinical pharmacists in the Nudge Study. Am J Health Syst Pharm. 2023 09 07; 80(18):1247-1254. PMID: 37353220.
      View in: PubMed
    3. Anderson SL, Marrs JC. Tirzepatide for type 2 diabetes. Drugs Context. 2023; 12. PMID: 37664792.
      View in: PubMed
    4. Vyas D, Park SK, Galal SM, Marrs JC, Williams E, Butler L. Using Emotional Intelligence as a Framework for Students' Professional Identity Formation. Am J Pharm Educ. 2023 Dec; 87(12):100569. PMID: 37419387.
      View in: PubMed
    5. Shah KK, Touchette DR, Marrs JC. Research and scholarly methods: measuring medication adherence. J Am Coll Clin Pharm. 2023; 6(4):416-426.
    6. Marrs JC, Formea CM, Abdalla M, Brual RL, Crowe SJ, Freibert KH, Herink MC, Hoffman AR, Philbrick AM, Prescott GM, Shahdoost Moghadam S, Zhou C. Call to action: Clinical pharmacist roles and opportunities in health disparities research. J Am Coll Clin Pharm. 2023; 3(6):297-304.
      View Publication
    7. Schubert TJ, Clegg K, Karalis D, Desai NR, Marrs JC, McNeal C, Mintz GL, Romagnoli KM, Jones LK. Impact of telehealth on the current and future practice of lipidology: a scoping review. J Clin Lipidol. 2023 Jan-Feb; 17(1):40-54. PMID: 36577629.
      View in: PubMed
    8. Marrs JC, Haidar CE. ASHP Statement on Pharmacist Prescribing of Statins. Am J Health Syst Pharm. 2022 11 22; 79(23):2182-2184. PMID: 36103398.
      View in: PubMed
    9. Anderson SL, Marrs JC. Diabetes: how to manage cardiovascular risk in secondary prevention patients. Drugs Context. 2022; 11. PMID: 35775074.
      View in: PubMed
    10. Butler L, Park SK, Vyas D, Cole JD, Haney JS, Marrs JC, Williams E. Evidence and Strategies for Including Emotional Intelligence in Pharmacy Education. Am J Pharm Educ. 2022 12; 86(10):ajpe8674. PMID: 34697015.
      View in: PubMed
    11. Glasgow RE, Knoepke CE, Magid D, Grunwald GK, Glorioso TJ, Waughtal J, Marrs JC, Bull S, Ho PM. The NUDGE trial pragmatic trial to enhance cardiovascular medication adherence: study protocol for a randomized controlled trial. Trials. 2021 Aug 11; 22(1):528. PMID: 34380527.
      View in: PubMed
    12. Adams JL, Law AV, Kawahara B, Godwin DA, Marrs JC, Ross LA, Rodin N, Shipman AJ, C?rdenas J. Report of the 2020-2021 Strategic Engagement Standing Committee. Am J Pharm Educ. 2021 11; 85(10):8715. PMID: 34301579.
      View in: PubMed
    13. Marrs JC, Cohen E. Impact of self-measured blood pressure monitoring on hypertension control. J Cardiol Clin Pract. 2021; 2(4):1-3.
    14. Nardolillo JA, Marrs JC, Anderson SL, Hanratty R, Saseen JJ. Retrospective cohort study of statin prescribing for primary prevention among people living with HIV. JRSM Cardiovasc Dis. 2021 Jan-Dec; 10:20480040211031068. PMID: 34290861.
      View in: PubMed
    15. White BM, Anderson SL, Marrs JC. Antihypertensive prescribing patterns and hypertension control in females of childbearing age. Am J Health Syst Pharm. 2021 07 09; 78(14):1317-1322. PMID: 33848330.
      View in: PubMed
    16. Cornelison P, Marrs JC, Anderson SL. Clinical Pharmacist Outreach to Increase Statin Use for Patients with Cardiovascular Disease in a Safety-Net Healthcare System. Am Health Drug Benefits. 2021 Jun; 14(2):63-69. PMID: 34267861.
      View in: PubMed
    17. Marrs JC, Anderson SL. Ertugliflozin in the treatment of type 2 diabetes mellitus. Drugs Context. 2020; 9. PMID: 33293984.
      View in: PubMed
    18. Marrs JC, Anderson SL. Bempedoic acid for the treatment of dyslipidemia. Drugs Context. 2020; 9. PMID: 32922503.
      View in: PubMed
    19. Anderson SL, Marrs JC, Chachas CR, Cichon BS, Cizmic AD, Calderon BB, Vlasimsky TB. Evaluation of a Pharmacist-Led Intervention to Improve Statin Use in Persons with Diabetes. J Manag Care Spec Pharm. 2020 Jul; 26(7):910-917. PMID: 32584671.
      View in: PubMed
    20. Anderson SL, Marrs JC. Can Direct Oral Anticoagulants Be Used for Stroke Prevention Among Patients with Valvular Atrial Fibrillation? Curr Cardiol Rep. 2019 08 31; 21(10):118. PMID: 31473836.
      View in: PubMed
    21. Wiggins BS, Dixon D, Bellone J, Gasbarro N, Marrs JC, Tran R. Key Articles and Guidelines in the Management of Dyslipidemia: 2019 Update. J Pharm Pract. 2020 Dec; 33(6):882-894. PMID: 31401932.
      View in: PubMed
    22. Anderson SL, Marrs JC. Sacubitril/valsartan: evaluation of safety and efficacy as an antihypertensive treatment. Drugs Context. 2018; 7:212542. PMID: 30116284.
      View in: PubMed
    23. Anderson SL, Marrs JC. A Review of the Role of the Pharmacist in Heart Failure Transition of Care. Adv Ther. 2018 03; 35(3):311-323. PMID: 29488151.
      View in: PubMed
    24. Luoma KA, Leavitt IM, Marrs JC, Nederveld AL, Regensteiner JG, Dunn AL, Glasgow RE, Huebschmann AG. How can clinical practices pragmatically increase physical activity for patients with type 2 diabetes? A systematic review. Transl Behav Med. 2017 12; 7(4):751-772. PMID: 28589531.
      View in: PubMed
    25. Jordan RP, Bratberg J, Congdon HB, Cross LB, Hill LG, Marrs JC, McBane S, Lang WG, Ekoma JO. The Report of the 2016-2017 Advocacy Standing Committee. Am J Pharm Educ. 2017 Oct; 81(8):S10. PMID: 29200458.
      View in: PubMed
    26. Anderson SL, Marrs JC. Antihyperglycemic Medications and Cardiovascular Risk Reduction. Eur Endocrinol. 2017 Aug; 13(2):86-90. PMID: 29632614.
      View in: PubMed
    27. Kelly MS, Saseen JJ, Marrs JC. Assessment of achieved systolic blood pressure in newly treated hypertensive patients aged 60-79 years before and after Eighth Joint National Committee recommendations. Ther Adv Cardiovasc Dis. 2017 Feb; 11(2):63-71. PMID: 28033742.
      View in: PubMed
    28. Anderson SL, Kattappuram RS, Marrs JC, Joseph NM. Intentional Brodifacoum Ingestion. Am J Med. 2017 Jan; 130(1):e27-e28. PMID: 27591180.
      View in: PubMed
    29. Marrs JC, Kostoff MD. Discontinuation of Statins: What Are the Risks? Curr Atheroscler Rep. 2016 Jul; 18(7):41. PMID: 27221503.
      View in: PubMed
    30. Marrs JC, Thompson AM. Antihypertensive Therapy in Females: A Clinical Review Across the Lifespan. Pharmacotherapy. 2016 06; 36(6):638-51. PMID: 27072935.
      View in: PubMed
    31. Zupec JF, Marrs JC, Saseen JJ. Evaluation of Statin Prescribing for Secondary Prevention in Primary Care Following New Guideline Recommendations. Ann Pharmacother. 2016 Jan; 50(1):17-21. PMID: 26416950.
      View in: PubMed
    32. Amin A, Marrs JC. Direct Oral Anticoagulants for the Management of Thromboembolic Disorders: The Importance of Adherence and Persistence in Achieving Beneficial Outcomes. Clin Appl Thromb Hemost. 2016 Oct; 22(7):605-16. PMID: 26316518.
      View in: PubMed
    33. Marrs JC. Duration of dual antiplatelet therapy after drug-eluting stents. N Engl J Med. 2015 04 02; 372(14):1372. PMID: 25830432.
      View in: PubMed
    34. Wobeter BR, Anderson SL, Marrs JC. Characterization of diastolic dysfunction heart failure following an acute hospitalization for heart failure in an urban, underserved population. Ther Adv Cardiovasc Dis. 2015 Oct; 9(5):267-74. PMID: 25767213.
      View in: PubMed
    35. Fosmire Rundgren EW, Anderson SL, Marrs JC. Response to comment "Evaluation of aspirin use for primary prevention in diabetic patients". Ann Pharmacother. 2015 Feb; 49(2):262-3. PMID: 25583942.
      View in: PubMed
    36. Fosmire Rundgren EW, Anderson SL, Marrs JC. Evaluation of aspirin use in patients with diabetes receiving care in community health. Ann Pharmacother. 2015 Feb; 49(2):170-7. PMID: 25288823.
      View in: PubMed
    37. Anderson SL, Marrs JC. Probable Interaction Between Warfarin and Divalproex Sodium. J Pharm Technol. 2014 Feb; 30(1):8-12. PMID: 34860893.
      View in: PubMed
    38. Anderson SL, Marrs JC, Vande Griend JP, Hanratty R. Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home. Popul Health Manag. 2013 Aug; 16(4):235-41. PMID: 23537153.
      View in: PubMed
    39. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the primary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e101-14. PMID: 23401140.
      View in: PubMed
    40. Baker WL, Marrs JC, Davis LE, Nutescu EA, Rowe AS, Ryan M, Splinter MY, Vardeny O, Fagan SC. Key articles and guidelines in the acute management and secondary prevention of ischemic stroke. Pharmacotherapy. 2013 Jun; 33(6):e115-42. PMID: 23401103.
      View in: PubMed
    41. Lowe RN, Marrs JC, Saseen JJ. Patterns of serum laboratory monitoring for safety and efficacy in patients on chronic statin therapy. Ther Adv Drug Saf. 2013 Feb; 4(1):9-17. PMID: 25083247.
      View in: PubMed
    42. Toussaint KA, Watson K, Marrs JC, Sturpe DA, Anderson SL, Haines ST. Prevalence of and factors that influence board certification among pharmacy practice faculty at United States colleges and schools of pharmacy. Pharmacotherapy. 2013 Jan; 33(1):105-11. PMID: 23307551.
      View in: PubMed
    43. Marrs JC. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl. Drugs Aging. 2012 May 01; 29(5):e1-e12. PMID: 22530704.
      View in: PubMed
    44. Anderson SL, Marrs JC. Dapagliflozin for the treatment of type 2 diabetes. Ann Pharmacother. 2012 Apr; 46(4):590-8. PMID: 22433611.
      View in: PubMed
    45. Marrs JC. Optimizing outcomes in patients with cardiovascular disease and chronic kidney disease. Am J Manag Care. 2011 Dec; 17 Suppl 15:S403-11. PMID: 22214475.
      View in: PubMed
    46. Haines ST, Andrus MR, Badowski M, Bradbury MM, Canales AE, Cavanaugh JM, Koval PG, Lee MW, Marrs JC, Michael Nash J, Ott CA, Robbins Williams A, Wham DL. Board Certification of Pharmacist Specialists. Pharmacotherapy. 2011 Nov; 31(11):1146-9. PMID: 22026401.
      View in: PubMed
    47. Hanselin MR, Saseen JJ, Allen RR, Marrs JC, Nair KV. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents. Hypertension. 2011 Dec; 58(6):1008-13. PMID: 22042809.
      View in: PubMed
    48. Marrs JC. Spironolactone management of resistant hypertension. Ann Pharmacother. 2010 Nov; 44(11):1762-9. PMID: 20978214.
      View in: PubMed
    49. Marrs JC, Saseen JJ. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis. Pharmacotherapy. 2010 Aug; 30(8):823-9. PMID: 20653359.
      View in: PubMed
    50. Williams CD, Marrs JC, Fields SA. Addition of a clinical pharmacist to an inpatient family medicine service. Am J Health Syst Pharm. 2010 Jun 15; 67(12):965-6. PMID: 20516461.
      View in: PubMed
    51. Marrs JC, Rackham DM. Residents' challenging role: Preceptee, preceptor, or both? Am J Health Syst Pharm. 2010 Feb 01; 67(3):239-43. PMID: 20101068.
      View in: PubMed
    52. Blair MM, Freitag RT, Keller DL, Kiser TH, Marrs JC, McGivney MS, Mohammad RA, Twedt EL. Proposed revision to the existing specialty and specialist certification framework for pharmacy practitioners. Pharmacotherapy. 2009 Apr; 29(4):3e-13e. PMID: 19323626.
      View in: PubMed
    53. Marrs JC. Colesevelam for the management of type 2 diabetes. Expert Opin Drug Metab Toxicol. 2009 Feb; 5(2):187-94. PMID: 19239397.
      View in: PubMed
    54. Marrs JC. Indiplon: a nonbenzodiazepine sedative-hypnotic for the treatment of insomnia. Ann Pharmacother. 2008 Jul; 42(7):1070-9. PMID: 18594049.
      View in: PubMed
    55. Marrs JC, Saseen JJ. Dyslipidemia control in indigent patients receiving medication assistance compared with insured patients. Pharmacotherapy. 2008 May; 28(5):562-9. PMID: 18447654.
      View in: PubMed
    56. Marrs JC, Saseen JJ. Which patients are candidates for dipeptidyl peptidase IV inhibitors? Am J Health Syst Pharm. 2007 Jun; 64(12):1261. PMID: 17563046.
      View in: PubMed
    57. Ito MK, Marrs J, Williams C. Omacor effects on serum lipids and clinical outcome. Am J Cardiol. 2007 Jan 01; 99(1):145. PMID: 17196478.
      View in: PubMed
    58. Marrs JC. Family medicine pharmacy residency programs. Am J Health Syst Pharm. 2006 Oct 01; 63(19):1803-5. PMID: 16990624.
      View in: PubMed
    Marrs's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (179) concept(s)
    _
    Co-Authors Expand Description
    See all (13) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department

    Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)